Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 1,900 | 8,036 | 1,385 | 1,250 | 3,358 |
| Operating Income | -1,900 | -8,036 | -1,385 | -1,250 | -3,358 |
| Interest Expense | -154 | 3,822 | 102 | 168 | 323 |
| Other Income | 0 | 0 | 0 | 0 | -1,068 |
| Pre-tax Income | -1,746 | -11,858 | -1,487 | -1,418 | -4,749 |
| Income Tax | 1 | 2 | 2 | 5 | 26 |
| Net Income Continuous | -1,747 | -11,860 | -1,489 | -1,423 | -4,775 |
| Minority Interests | -9 | N/A | -17 | -50 | -144 |
| Net Income | $-1,738 | $-11,860 | $-1,472 | $-1,373 | $-4,631 |
| EPS Basic Total Ops | 261.37 | -274.25 | -197.80 | -184.26 | -532.22 |
| EPS Basic Continuous Ops | 270.09 | -275.81 | -200.08 | -190.95 | -596.07 |
| EPS Diluted Total Ops | 261.37 | -274.25 | -197.80 | -184.26 | -532.22 |
| EPS Diluted Continuous Ops | 270.09 | -275.81 | -200.08 | -190.95 | -596.07 |
| EPS Diluted Before Non-Recurring Items | N/A | -273.94 | -792.13 | N/A | N/A |
| EBITDA(a) | $-1,912 | $-8,014 | $-1,378 | $-1,242 | $-3,352 |